At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 80 enrolled
Drug / intervention
Liposomal bupivacaine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Liposomal Bupivacaine at Cesarean Delivery to Decrease Post-operative Pain
In Brief
A Phase 3 clinical trial evaluating Liposomal bupivacaine and Placebo for Pain, Postoperative. Completed, enrolled 80 participants across 1 site.
Detailed Summary
This is a randomized controlled trial to test whether the use of liposomal bupivacaine at the time of cesarean delivery may decrease post-operative pain scores.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain, Postoperative
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
2017201820192020202120222023202420252026
First PostedNov 2016
Enrollment StartMar 2017
Primary CompletionSep 2017
Study CompletionNov 2017
TodayJul 2026
First PostedNov 9, 2016
Enrollment StartMar 8, 2017
Primary CompletionSep 25, 2017
Study CompletionNov 3, 2017
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 9.6 years ago
Interventions
Liposomal bupivacainedrug
liposomal bupivacaine injection in the Pfannenstiel incision
Placebodrug
placebo injection in the Pfannenstiel incision